• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

Marijuana Stocks To Watch - Monday, June 26th

June 26, 2017

 

Based on recent news and market movement in the early part of the trading day, here are a handful of marijuana stocks we'll be keeping an eye on through the rest of today's trading session. 

 

Cara Therapeutics, Inc. (NASDAQ:CARA) 

 

In early trading Monday, shares of Cara Therapeutics are up more than 8% after gaining more than 35% last week. On Friday, one of Cara's non-cannabinoid products was granted a Breakthrough Therapy designation by the FDA. Given all of this bullishness, we'll be watching shares of Cara through the rest of the trading day to see if they pause here or continue to march higher. 

 

GB Sciences, Inc. (OTC:GBLX)

 

Shares of GB Sciences are up more than 3% in early trading Monday. This morning, the company announced that they have secured their bid to cultivate and sell medical marijuana for Louisiana State University's AgCenter. We'll be watching to see how shares of GB Sciences finish out today's trading session. 

 

India Globalization Capital, Inc. (NYSE:IGC) 

 

In early trading Monday, shares of India Globalization Capital are up more than 25% on volume that is already more than 3x the company's 30-day average volume. Given this early breakout, we'll be watching shares of India Globalization Capital closely through the rest of the trading day. 

 

22nd Century Group, Inc. (NYSE:XXII) 

 

Last week, it was announced that 22nd Century Group is being added to the Russell Microcap Index. This is usually a bullish signal as funds that track the index will now have to buy shares of 22nd Century to meet their investment mandates. In early trading Monday, shares of XXII are down 1.5%. We'll be watching to see how 22nd Century finishes out today's trading. 

 

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE)

 

Effective last Friday, Zynerba Pharmaceuticals was added to the Russell 3000 Index. This is usually a bullish signal as funds that track the Russell 3000 index will now have to own shares of Zynerba to meet their investment mandates. Additionally, this morning, Zynerba announced that they are initiating Phase 1 clinical trials of their THC-based transdermal patch. In early trading Monday, shares of ZYNE are down more than 0.5%

 

Conclusion
 
That's all we have for now, but we'll be sure to keep readers posted regarding important developments in these names and in the cannabis industry worldwide. Remember that four of the stocks to watch today (Cara TherapeuticsIndia Globalization Capital, Zynerba Pharmaceuticals and  22nd Century Group) can be traded for free using the Robinhood App

Be sure to subscribe to one or more of our free newsletters so you never miss an important update! Also, don't forget to connect with The Daily Marijuana Observer on Facebook, Twitter, and Instagram.

 

D/M/O

 

Disclaimer

 

Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.

Please reload

LATEST NEWS
Please reload

Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.